SEPN

Septerna, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$25.18

Market Cap

$1.13B

Beta

3.46

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+4174.51%

EPS Growth (YoY)+40.32%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield+9.70%

Debt / Equity0.06

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for SEPN.